InsidersTradesSigma
지투지바이오: management transactions · South Korea · DART (FSS)
DART:company-57d197KR·DART (FSS)Mcap 1021.0Bn€Healthcare
Browse the full directors' dealings record of 지투지바이오, a publicly traded company based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Healthcare sector, 지투지바이오 has recorded 5 reports. Market capitalisation: €1,021bn. The latest transaction was filed on 27 March 2026 (Purchase). Among the most active insiders: 이희용. All data is free.
5
Insider Decl.
0
Thresholds
€126,583
5 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
62800.00 €
Analyst consensus
Income statement
Revenue423.1 M€
Gross profit−33.5 M€-8% margin
Net income−12.09 Bn€-2857.1% margin
Balance sheet & cash
Market cap1021.04 Bn€
Total debt7.13 Bn€
Free Cash Flow−14.25 Bn€
Profitability & ownership
% insiders16.8%
% institutions10.0%
Last declaration on 27 March 2026
Declarations5 total
5 of 5 declarations